
ODN 1826
CAS No. 202668-42-6
ODN 1826( —— )
Catalog No. M36602 CAS No. 202668-42-6
ODN 1826 is a 20-mer DNA strand, a TLR9 agonist and an immunostimulant, with anti-tumor and cardioprotective effects, promoting apoptosis, and stimulating the production of NO and iNOS. ODN 1826 is a CpG DNA mimetic that can be used as an adjuvant for synthetic vaccines.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameODN 1826
-
NoteResearch use only, not for human use.
-
Brief DescriptionODN 1826 is a 20-mer DNA strand, a TLR9 agonist and an immunostimulant, with anti-tumor and cardioprotective effects, promoting apoptosis, and stimulating the production of NO and iNOS. ODN 1826 is a CpG DNA mimetic that can be used as an adjuvant for synthetic vaccines.
-
DescriptionODN 1826 (CpG 1826), a class B CpG ODN (oligodeoxynucleotide), is a TLR9 agonist. ODN 1826 promotes Apoptosis. ODN 1826 is an excellent immune stimulator with antitumor activity. ODN 1826 has protective effects on the heart. ODN 1826 sequence: 5’-tccatgacgttcctgacgtt-3’.
-
In VitroWestern Blot Analysis Cell Line:RAW 264.7 Concentration:1 μg/mL Incubation Time:24 h Result:Increased the production of NO and iNOS.
-
In VivoAnimal Model:Chronic vascular injury mouse models Dosage:18 nM CPG ODN Administration:s.c,three times a week for 7 weeks Result:Increased in aortic atherosclerotic plaque size compared to vehicle.Animal Model:Lewis Lung Cancer Murine Tumor ModelDosage:0.05 mg (1, 3, 5, 8, 11, 13 days) Administration:Intraperitoneal injection (i.p.)Result:Delayed tumor growth,decreased tumor weight and increased the apoptosis of tumor cells.
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR | NOS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number202668-42-6
-
Formula Weight6364.1
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (7.86 mM; Ultrasonic)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Krogmann AO, et al. Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice. PLoS One. 2016 Jan 11;11(1):e0146326.?
molnova catalog



related products
-
CEP-40783
CEP-40783 is an effective, specific and orally active AXL/c-Met inhibitor (IC50: 7/12 nM). It also inhibits MER and TYRO3 (IC50: 29/19 nM).
-
CPG-52364
CPG-52364 (CPG52364) is an orally available, small molecule TLR7/8/9 antagonist for the treatment of systemic lupus erythematosus and other autoimmune disorders.
-
CU-CPT-9a
CU-CPT-9a is a potent TLR8 inhibitor (IC50 : 0.5 nM) that suppresses TLR8-mediated proinflammatory signaling in various cell lines.